157 related articles for article (PubMed ID: 16189758)
1. [Perioperative / peri-interventional anticoagulation].
Voss R; Grebe M
Dtsch Med Wochenschr; 2005 Sep; 130(39):2209-12. PubMed ID: 16189758
[No Abstract] [Full Text] [Related]
2. [Recurrent thrombosis of a mitral mechanical heart valve prosthesis during puerperium--a case report].
Lisowska A; Prokop J; Hirnle T; Juszczyk G; Skibińska E; Musiał WJ; Klonowska-Dziatkiewicz E
Kardiol Pol; 2004 Jul; 61(7):49-51; discussion 52. PubMed ID: 15338018
[TBL] [Abstract][Full Text] [Related]
3. Perioperative anticoagulation: looking through heparin window.
Hartsell ZC; Will KK
JAAPA; 2004 Jun; 17(6):21-5; quiz 33-4. PubMed ID: 15314875
[No Abstract] [Full Text] [Related]
4. eComment: Are low molecular weight heparin effective in mechanical valve prosthesis anticoagulation during pregnancy?
Carrascal Y
Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):118-9. PubMed ID: 20019046
[No Abstract] [Full Text] [Related]
5. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
[No Abstract] [Full Text] [Related]
6. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
[TBL] [Abstract][Full Text] [Related]
7. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.
Meurin P; Tabet JY; Weber H; Renaud N; Ben Driss A
Circulation; 2006 Jan; 113(4):564-9. PubMed ID: 16449734
[TBL] [Abstract][Full Text] [Related]
9. Acute thrombosis of a prosthetic mitral valve in pregnancy in spite of adjusted-dose low-molecular-weight heparin and aspirin.
Curtis SL; Trinder J; Stuart AG
J Heart Valve Dis; 2008 Jan; 17(1):133-4. PubMed ID: 18365582
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
Descarries LM; Leduc L; Khairy P; Mercier LA
J Heart Valve Dis; 2006 Sep; 15(5):679-85. PubMed ID: 17044374
[TBL] [Abstract][Full Text] [Related]
11. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey.
Kulik A; Rubens FD; Baird D; Wells PS; Kearon C; Mesana TG; Lam BK
J Heart Valve Dis; 2006 Jul; 15(4):581-7. PubMed ID: 16901058
[TBL] [Abstract][Full Text] [Related]
12. Natural course of left atrial thrombi after bioprosthetic mitral valve replacement in a patient with heparin-induced thrombocytopenia.
Abraham BK; Chow CM; Latter DA; Mazer CD
Can J Cardiol; 2005 Dec; 21(14):1307-8. PubMed ID: 16341302
[TBL] [Abstract][Full Text] [Related]
13. eComment: Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
Bockeria LA; Skopin II; Kuts EV
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1169. PubMed ID: 19029395
[No Abstract] [Full Text] [Related]
14. [Use of low-molecular-weight heparins in patients with prosthetic heart valves].
Hering D; Horstkotte D
Dtsch Med Wochenschr; 2003 May; 128(20):1129-33. PubMed ID: 12748904
[No Abstract] [Full Text] [Related]
15. Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement.
Banach M; Goch A; Misztal M; Rysz J; Jaszewski R; Goch JH
J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1569-76. PubMed ID: 18023685
[TBL] [Abstract][Full Text] [Related]
16. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
Helft G; Gilard M; Le Feuvre C; Zaman AG
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
18. State of the art anticoagulation management.
Piper C; Horstkotte D
J Heart Valve Dis; 2004 May; 13 Suppl 1():S76-80. PubMed ID: 15225010
[No Abstract] [Full Text] [Related]
19. Bivalirudin for prevention of prosthetic valve thrombosis in heparin allergy.
Palacios-Rubio J; Cano L; Vilacosta I; Vivas D
J Card Surg; 2013 Sep; 28(5):520-1. PubMed ID: 23909407
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation therapy in patients with prosthetic heart valves.
Douketis JD
Clin Adv Hematol Oncol; 2007 Jun; 5(6):436-8. PubMed ID: 17679917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
